BILL · 2013–14 SESSION
SB 5469: Biological product prescrips
Concerning the prescription of biological products and interchangeable biosimilar products.
Summary
- Addresses prescriptions for biological products and interchangeable biosimilar products.
From the Bill Digest (SB 5469), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 31, 2013
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Senator (D-46)
- Introduced
- January 31, 2013 in the Senate
- Last action
- January 13, 2014
- Companion bill
- HB 1528
AN ACT Relating to the prescription of biological products and interchangeable biosimilar products;
Sponsors
Prime sponsor: Senator (D-46)
8 co-sponsors (5 Democrats, 3 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care.
SB 5469 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5469 (2025–26) Rental housing market
- SB 5469 (2023–24) Covenant homeownership prg.
- SB 5469 (2021–22) Civil penalties/COVID-19
- SB 5469 (2019–20) PEBB retiree premiums
- SB 5469 (2017–18) Automatic voter registration
- SB 5469 (2015–16) Education employee COLAs
- SB 5469 (2011–12) Boards and commissions
- SB 5469 (2009–10) Intermediate vehicle license